.OncoC4 is taking AcroImmune-- and also its own internal medical manufacturing capabilities-- under ...
.Amgen has actually discussed (PDF) the 1st period 3 information on its own $400 thousand dermatitis...
.Biogen and UCB's bank on developing in to period 3 astride a failed research study looks to have ac...
.Italian biotech Aptadir Rehabs has introduced along with the assurance that its pipeline of preclin...
.Wave Life Sciences has met its goal in a Duchenne muscle dystrophy (DMD) research, positioning it t...
.After a couple of years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, occupying...
.Achilles Therapeutics has torn up its strategy. The English biotech is actually stopping work on it...
.Aligos Therapeutics is proclaiming a midstage gain in metabolic-dysfunction associated steatohepati...
.Basilea Pharmaceutica's job cultivating brand-new antifungals has received a significant increase f...
.Possessing actually scooped up the united state legal rights to Capricor Therapeutics' late-stage D...